Abstract:Purpose: Nanoparticles (NPs) decorated with functional ligands are promising candidates for cancer diagnosis and treatment. However, numerous studies have shown that chemically coupled targeting moieties on NPs lose their targeting capability in the biological milieu because they are shielded or covered by a "protein corona". Herein, we construct a functional magnetosome that recognizes and targets cancer cells even in the presence of protein corona. Methods: Magnetosomes (BMPs) were extracted from magnetotactic bacteria, M. gryphiswaldense (MSR-1), and decorated with trastuzumab (TZ) via affibody (RA) and glutaraldehyde (GA). The engineered BMPs are referred to as BMP-RA-TZ and BMP-GA-TZ. Their capacities to combine HER2 were detected by ELISA, the quantity of plasma corona proteins was analyzed using LC-MS. The efficiencies of targeting SK-BR-3 were demonstrated by confocal laser scanning microscopy and flow cytometry. Results: Both engineered BMPs contain up to ~0.2 mg TZ per mg of BMP, while the quantity of HER2 binding to BMP-RA-TZ is three times higher than that binding to BMP-GA-TZ. After incubation with normal human plasma or IgG-supplemented plasma, GA-TZ-containing BMPs have larger hydrated radii and more surface proteins in comparison with RA-TZ-containing BMPs. The TZ-containing BMPs all can be targeted to and internalized in the HER2-overexpressing breast cancer cell line SK-BR-3; however, their targeting efficiencies vary considerably: 50-75% for RA-TZ-containing BMPs and 9-19% for GA-TZ-containing BMPs. BMPs were incubated with plasma (100%) and cancer cells to simulate human in vivo environment. In this milieu, BMP-RA-TZ uptake efficiency of SK-BR-3 reaches nearly 80% (slightly lower than for direct interaction with BMP-RA-TZ), whereas the BMP-GA-TZ uptake efficiency is <17%. Conclusion: Application of the RA scaffold promotes and orients the arrangement of targeting ligands and reduces the shielding effect of corona proteins. This strategy improves the targeting capability and drug delivery of NP in a simulated in vivo milieu.

Targeting Ability of Affibody-Functionalized Particles is Enhanced by Albumin but Inhibited by Serum Coronas

Regulation of protein corona on liposomes using albumin-binding peptide for targeted tumor therapy

The Effects of Serum Albumin Pre-Adsorption of Nanoparticles on Protein Corona and Membrane Interaction: A Molecular Simulation Study

Protein corona of nanoparticles: distinct proteins regulate the cellular uptake.

Computer Simulation of the Role of Protein Corona in Cellular Delivery of Nanoparticles.

Serum-derived Protein Coronas Affect Nanoparticle Interactions with Brain Cells

Revealing The Binding Structure Of The Protein Corona On Gold Nanorods Using Synchrotron Radiation-Based Techniques: Understanding The Reduced Damage In Cell Membranes

Artificial engineering of the protein corona at bio-nano interfaces for improved cancer-targeted nanotherapy

Polymer-coated nanoparticle protein corona formation potentiates phagocytosis of bacteria by innate immune cells and inhibits coagulation in human plasma.

Corona of Thorns: the Surface Chemistry-Mediated Protein Corona Perturbs the Recognition and Immune Response of Macrophages

Versatile Protein Coronation Approach with Multiple Depleted Serum for Creating Biocompatible, Precision Nanomedicine.

Polymer Brush-Grafted Nanoparticles Preferentially Interact with Opsonins and Albumin

Prominent Enhancement of Peptide-mediated Targeting Efficiency for Human Hepatocellular Carcinomas With Composition-engineered Protein Corona on Gold Nanoparticles

Protein Coronas Derived from Cerebrospinal Fluid Enhance the Interactions Between Nanoparticles and Brain Cells

The effects of aggregation and protein corona on the cellular internalization of iron oxide nanoparticles

Serum proteins on nanoparticles: early stages of the “protein corona”

The protein corona and its effects on nanoparticle-based drug delivery systems

Protein Corona Significantly Reduces Active Targeting Yield.

Unmasking CSF protein corona: Effect on targeting capacity of nanoparticles

Strategy for Avoiding Protein Corona Inhibition of Targeted Drug Delivery by Linking Recombinant Affibody Scaffold to Magnetosomes

Monitoring of the Enzymatic Degradation of Protein Corona and Evaluating the Accompanying Cytotoxicity of Nanoparticles